We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Rapid Agglutination Latex Test Developed for Diarrheagenic Pathogens

By LabMedica International staff writers
Posted on 08 Oct 2014
Print article
Image: The agglutination latex assay for enteropathogenic and enterohemorrhagic Escherichia coli; negative (-) and a semi-quantitative positive (from + to ++++) agglutination pattern with anti-EspB monoclonal coated beads (Photo courtesy of Instituto Butantan).
Image: The agglutination latex assay for enteropathogenic and enterohemorrhagic Escherichia coli; negative (-) and a semi-quantitative positive (from + to ++++) agglutination pattern with anti-EspB monoclonal coated beads (Photo courtesy of Instituto Butantan).
Image: The Multiskan EX enzyme linked immunosorbent assay (ELISA) reader (Photo courtesy of Thermo Scientific).
Image: The Multiskan EX enzyme linked immunosorbent assay (ELISA) reader (Photo courtesy of Thermo Scientific).
Enteropathogenic and enterohemorrhagic Escherichia coli (EPEC/EHEC) are human intestinal pathogens responsible for diarrhea in both developing and industrialized countries.

A rapid and simple assay for EPEC/EHEC detection has been developed using the EPEC/EHEC-secreted proteins EspA and EspB, which were chosen as target antigens since they are the major secreted proteins in both pathogens.

Bacteriologists at the Instituto Butantan (São Paulo, Brazil) analyzed 71 atypical EPEC (aEPEC), 31 typical EPEC (tEPEC), and 23 EHEC belonging to different serotypes characterized as locus of enterocyte effacement (LEE)-positive isolates. The secreted proteins EspA and EspB were detected using an enzyme linked immunosorbent assay and the absorbance was measured at 492 nm in a Multiskan EX ELISA reader (Thermo Scientific; Waltham, MA, USA).

For rapid agglutination latex test (RALT), bacterial isolates were grown on Dulbecco’s modified Eagle’s medium (DMEM)-agar and the tests were done using latex sensitized with anti-EspB monoclonal antibody (MAb). The RALT was performed on a slide glass using 20 µL of bacterial lysate and 20 µL of latex beads coupled to anti-EspB (MAb), and checking for agglutination after five minutes of gentle mixing. The EspB secreted protein was defined as a biomarker and its corresponding monoclonal antibody as the tool for EPEC/EHEC diagnosis; the production of EspB was better in DMEM medium.

The indirect ELISA using anti-EspB MAb showed 90.4% sensitivity and 96.4%, specificity, indicating its possible use in routine diagnostic laboratories. However, this methodology requires specific laboratory instrumentation, making it difficult to be performed in low-income country settings. The RALT assay can be considered an alternative assay for diarrhea diagnosis in low-income countries since it achieved 97% sensitivity, 98% specificity and 97% efficiency. RALT assay has the sensitivity and specificity required for high-impact diagnosis of neglected diseases in the developing world.

The authors concluded that serotyping-based diagnosis is the only methodology available in limited-resources settings, employing either commercial or in-house antisera. The standardized RALT for detection of EPEC and EHEC will have a remarkable impact in the diagnosis of these pathotypes, as the established agglutination latex test is a simple, rapid and easy to perform test, which can be employed in less equipped laboratories in low-income countries. The study was published on September 25, 2014, in the Public Library of Science Neglected Tropical Diseases.

Related Links:

Instituto Butantan 
Thermo Scientific


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Liquid biopsy could detect and monitor aggressive small cell lung cancer (Photo courtesy of Shutterstock)

Blood-Based Test Detects and Monitors Aggressive Small Cell Lung Cancer

Small cell lung cancer (SCLC) is a highly aggressive type of cancer known for its ability to metastasize. The behavior of tumors is largely governed by which genes are turned on, or transcribed, irrespective... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.